...
apre-img

Aprea Therapeutics Inc, Common Stock

APRE

NAQ

$3.195

-$0.32

(-9.09%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$19.57M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
25.11K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.74
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.15 L
$8.85 H
$3.195

About Aprea Therapeutics Inc, Common Stock

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors. The company is also developing ATRN-1051 for the treatment of ovarian cancer; and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameAPRESectorS&P500
1-Week Return-8.71%-2.27%-0.57%
1-Month Return-3.16%-3.96%1.21%
3-Month Return1.43%-9.7%7.57%
6-Month Return-24.47%-3.37%11.45%
1-Year Return-18.49%3.71%28.48%
3-Year Return-95.77%3.8%29.52%
5-Year Return-99.57%39.78%90.66%
10-Year Return-99.22%106.91%203.75%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue----583.23K[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue170.25K229.61K271.68K186.44K7.05K[{"date":"2019-12-31","value":62.67,"profit":true},{"date":"2020-12-31","value":84.52,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":68.63,"profit":true},{"date":"2023-12-31","value":2.6,"profit":true}]
Gross Profit(170.25K)(229.61K)(271.68K)(186.44K)576.18K[{"date":"2019-12-31","value":-29.55,"profit":false},{"date":"2020-12-31","value":-39.85,"profit":false},{"date":"2021-12-31","value":-47.15,"profit":false},{"date":"2022-12-31","value":-32.36,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)98.79%[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses29.54M52.81M37.45M37.37M16.05M[{"date":"2019-12-31","value":55.94,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":70.91,"profit":true},{"date":"2022-12-31","value":70.77,"profit":true},{"date":"2023-12-31","value":30.39,"profit":true}]
Operating Income(31.04M)(52.15M)(38.04M)38.18M(15.47M)[{"date":"2019-12-31","value":-81.31,"profit":false},{"date":"2020-12-31","value":-136.59,"profit":false},{"date":"2021-12-31","value":-99.62,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-40.52,"profit":false}]
Total Non-Operating Income/Expense3.14M(444.95K)320.70K(74.84M)2.34M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-14.17,"profit":false},{"date":"2021-12-31","value":10.22,"profit":true},{"date":"2022-12-31","value":-2384.06,"profit":false},{"date":"2023-12-31","value":74.61,"profit":true}]
Pre-Tax Income(28.06M)(53.48M)(37.13M)(112.66M)(14.29M)[{"date":"2019-12-31","value":-2805980700,"profit":false},{"date":"2020-12-31","value":-5347881200,"profit":false},{"date":"2021-12-31","value":-3712730300,"profit":false},{"date":"2022-12-31","value":-11266202700,"profit":false},{"date":"2023-12-31","value":-1428675600,"profit":false}]
Income Taxes(1.65M)437.99K(590.73K)112.21M(2.00)[{"date":"2019-12-31","value":-1.47,"profit":false},{"date":"2020-12-31","value":0.39,"profit":true},{"date":"2021-12-31","value":-0.53,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(26.41M)(53.92M)(36.54M)(224.88M)(14.29M)[{"date":"2019-12-31","value":-2640506200,"profit":false},{"date":"2020-12-31","value":-5391680200,"profit":false},{"date":"2021-12-31","value":-3653657600,"profit":false},{"date":"2022-12-31","value":-22487538700,"profit":false},{"date":"2023-12-31","value":-1428675400,"profit":false}]
Income From Continuous Operations(28.06M)(53.48M)(37.13M)(112.66M)(13.29M)[{"date":"2019-12-31","value":-2805980700,"profit":false},{"date":"2020-12-31","value":-5347881200,"profit":false},{"date":"2021-12-31","value":-3712730300,"profit":false},{"date":"2022-12-31","value":-11266202700,"profit":false},{"date":"2023-12-31","value":-1328564400,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(26.41M)(53.92M)(36.54M)(224.88M)(14.29M)[{"date":"2019-12-31","value":-2640506200,"profit":false},{"date":"2020-12-31","value":-5391680200,"profit":false},{"date":"2021-12-31","value":-3653657600,"profit":false},{"date":"2022-12-31","value":-22487538700,"profit":false},{"date":"2023-12-31","value":-1428675600,"profit":false}]
EPS (Diluted)(118.91)(50.80)(35.00)(30.12)(3.99)[{"date":"2019-12-31","value":-11891,"profit":false},{"date":"2020-12-31","value":-5080,"profit":false},{"date":"2021-12-31","value":-3500,"profit":false},{"date":"2022-12-31","value":-3012,"profit":false},{"date":"2023-12-31","value":-399,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

APRE
Cash Ratio 7.22
Current Ratio 7.28

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

APRE
ROA (LTM) -30.26%
ROE (LTM) -50.11%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

APRE
Debt Ratio Lower is generally better. Negative is bad. 0.18
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.82

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

APRE
Trailing PE NM
Forward PE NM
P/S (TTM) 13.61
P/B 0.79
Price/FCF NM
EV/R 0.00
EV/Ebitda 0.35

FAQs

What is Aprea Therapeutics Inc share price today?

Aprea Therapeutics Inc (APRE) share price today is $3.195

Can Indians buy Aprea Therapeutics Inc shares?

Yes, Indians can buy shares of Aprea Therapeutics Inc (APRE) on Vested. To buy Aprea Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in APRE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Aprea Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Aprea Therapeutics Inc (APRE) via the Vested app. You can start investing in Aprea Therapeutics Inc (APRE) with a minimum investment of $1.

How to invest in Aprea Therapeutics Inc shares from India?

You can invest in shares of Aprea Therapeutics Inc (APRE) via Vested in three simple steps:

  • Click on Sign Up or Invest in APRE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Aprea Therapeutics Inc shares
What is Aprea Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Aprea Therapeutics Inc (APRE) is $8.85. The 52-week low price of Aprea Therapeutics Inc (APRE) is $2.15.

What is Aprea Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Aprea Therapeutics Inc (APRE) is

What is Aprea Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Aprea Therapeutics Inc (APRE) is 0.79

What is Aprea Therapeutics Inc dividend yield?

The dividend yield of Aprea Therapeutics Inc (APRE) is 0.00%

What is the Market Cap of Aprea Therapeutics Inc?

The market capitalization of Aprea Therapeutics Inc (APRE) is $19.57M

What is Aprea Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Aprea Therapeutics Inc is APRE

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top